investigational medicinal products (IMP)

Operating clinical studies with a silo mentality with undoubtedly yield poor results. With various risks associated at each stage Adrian Collins, Almac Clinical Services, explores the hidden challenges of clinical packaging and how to overcome them… Read more


Aesica Pharmaceuticals has established a new Quality Assurance team focused on delivering a range of QP services across oral, topical, inhalable and parenteral dosage forms in Investigational Medicinal Products (IMP) clinical trial release... Read more